{"id":11338,"date":"2022-07-01T20:33:33","date_gmt":"2022-07-02T00:33:33","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/is-immunotherapy-an-option-for-colorectal-cancer-patients-with-dr-dung-le\/"},"modified":"2022-07-14T16:06:38","modified_gmt":"2022-07-14T20:06:38","slug":"is-immunotherapy-an-option-for-colorectal-cancer-p","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p","title":{"rendered":"Is Immunotherapy an Option for Colorectal Cancer Patients, with Dr. Dung Le"},"content":{"rendered":"<p><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/GRp2mHBs6xs\" width=\"560\"><\/iframe><\/p>\n<p>Colorectal cancer treatment is undergoing a revolution thanks to advances in cancer immunotherapy and drugs that mobilize patients&#39; immune systems to fight cancer.<\/p>\n<p>In this webinar for patients and caregivers, immunotherapy expert Dr. Dung Le of the Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center describes what patients need to know about the current treatment landscape, how immunotherapy is changing treatment, and what&#39;s in store for clinical trials and future treatment strategies.<\/p>\n<p>This webinar is part of the Cancer Research Institute &quot;Cancer Immunotherapy and You&quot; webinar series sponsored by Bristol-Myers Squibb, Genentech, and Regeneron.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Dung Le of the Johns Hopkins&nbsp;describes what patients need to know about the current treatment landscape, how immunotherapy is changing treatment, and what&#39;s in store for clinical trials and future treatment strategies.<\/p>\n","protected":false},"featured_media":5661,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11338","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Is Immunotherapy an Option for Colorectal Cancer Patients<\/title>\n<meta name=\"description\" content=\"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is Immunotherapy an Option for Colorectal Cancer Patients\" \/>\n<meta property=\"og:description\" content=\"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:06:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c9593e73-fbcb-451a-b954-376988e3eb7f.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Is Immunotherapy an Option for Colorectal Cancer Patients\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c9593e73-fbcb-451a-b954-376988e3eb7f.png\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p\",\"name\":\"Is Immunotherapy an Option for Colorectal Cancer Patients\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f4dfb6dc-9f9b-41ec-9c36-bd54765c0c03.png\",\"datePublished\":\"2022-07-02T00:33:33+00:00\",\"dateModified\":\"2022-07-14T20:06:38+00:00\",\"description\":\"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f4dfb6dc-9f9b-41ec-9c36-bd54765c0c03.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f4dfb6dc-9f9b-41ec-9c36-bd54765c0c03.png\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Is Immunotherapy an Option for Colorectal Cancer Patients, with Dr. Dung Le\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is Immunotherapy an Option for Colorectal Cancer Patients","description":"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p","og_locale":"es_ES","og_type":"article","og_title":"Is Immunotherapy an Option for Colorectal Cancer Patients","og_description":"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.","og_url":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:06:38+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c9593e73-fbcb-451a-b954-376988e3eb7f.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Is Immunotherapy an Option for Colorectal Cancer Patients","twitter_description":"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c9593e73-fbcb-451a-b954-376988e3eb7f.png","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p","url":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p","name":"Is Immunotherapy an Option for Colorectal Cancer Patients","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f4dfb6dc-9f9b-41ec-9c36-bd54765c0c03.png","datePublished":"2022-07-02T00:33:33+00:00","dateModified":"2022-07-14T20:06:38+00:00","description":"Dr. Dung Le of the Johns Hopkins\u00a0describes what patients need to know about the current treatment landscape.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f4dfb6dc-9f9b-41ec-9c36-bd54765c0c03.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f4dfb6dc-9f9b-41ec-9c36-bd54765c0c03.png","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/is-immunotherapy-an-option-for-colorectal-cancer-p#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Is Immunotherapy an Option for Colorectal Cancer Patients, with Dr. Dung Le"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/5661"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11338"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11338"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11338"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11338"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11338"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11338"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}